Introduction

Serum amyloid A (SAA) is an important acute-phase protein in horses that can help veterinarians assess inflammation, investigate suspected infection and monitor a horse's response to treatment. Because SAA can rise rapidly in response to inflammatory stimuli and decrease as the inflammatory process resolves, measuring it over time can provide useful information alongside clinical examination and other diagnostic findings.

For equine veterinarians, performance-horse practitioners, breeding operations and mixed veterinary practices, equine SAA testing can be a valuable addition to a structured diagnostic and monitoring plan.

What Is Serum Amyloid A (SAA) in Horses?

Serum amyloid A is an acute-phase protein produced primarily by the liver in response to inflammatory signals in the body. Its concentration in the blood can increase substantially during acute inflammation, including inflammation associated with infection, tissue injury and certain other diseases.

In healthy horses, circulating SAA concentrations are generally low. When an inflammatory response develops, SAA may increase rapidly, sometimes before other routine laboratory indicators show a clear change. As the inflammatory stimulus resolves, SAA can fall relatively quickly, making it useful for monitoring changes over time.

Important: SAA is a marker of inflammation, not a diagnosis of a specific disease. An increased result must be interpreted alongside the horse's clinical signs, history, examination and other appropriate investigations.

Why Is Equine SAA Testing Important?

Horses can develop inflammatory conditions affecting many body systems. Equine SAA testing can help veterinarians consider whether a systemic inflammatory response may be present, whether it is changing, whether the horse appears to be responding to treatment, and whether further investigation may be warranted.

• Is there evidence of a significant systemic inflammatory response?

• Is inflammation increasing or decreasing?

• Is the horse responding to treatment as expected?

• Does the clinical picture suggest that further investigation is needed?

• Is the horse recovering as anticipated following surgery or another significant clinical event?

SAA provides an additional objective measurement that can be considered alongside physical examination, temperature, heart rate, appetite, pain, blood counts and other relevant tests.

How Can SAA Support Clinical Assessment?

1. Investigating Suspected Infection

SAA can increase in horses experiencing inflammatory responses associated with bacterial infections and other infectious conditions. A raised result may support concern about significant inflammation and help a veterinarian decide whether additional investigations are appropriate. It may be useful when assessing a horse with fever, reduced appetite, lethargy, respiratory signs or other findings suggestive of infection.

SAA does not identify the organism responsible or establish the location of an infection. Clinical examination, appropriate sampling, imaging, culture or other diagnostic procedures may still be required.

2. Monitoring Postoperative Recovery

After surgery, veterinarians need to distinguish an expected recovery response from a potentially concerning clinical course. Serial SAA measurements may help assess the inflammatory trend. A decline consistent with clinical improvement can be reassuring, while persistently increased or rising concentrations may prompt reassessment.

Results must be interpreted in the context of the procedure, expected postoperative response and the horse's overall condition. An increase alone does not prove that a complication has developed.

3. Assessing Inflammatory Conditions

SAA can support assessment of inflammatory disease involving different systems, including gastrointestinal, respiratory, reproductive and musculoskeletal conditions. It should not be used in isolation to diagnose colic, pneumonia, joint infection or any specific condition.

4. Supporting Monitoring During Treatment

Following SAA serially can provide another measure of the inflammatory response during treatment. A decreasing trend may support a favourable response when it agrees with the horse's clinical progress. If SAA remains elevated, stops decreasing or rises again, the veterinarian may consider further examination, diagnostic testing or a review of the treatment plan. Decisions should be based on the full clinical picture rather than a laboratory value alone.

Why Serial SAA Testing Is Often More Informative Than One Result

A single SAA measurement provides a snapshot of the horse's inflammatory status at a particular time. Repeating the measurement can help show whether the inflammatory response is changing.

These are general interpretive patterns, not universal diagnostic rules. Timing, disease stage, treatment, assay characteristics and the horse's clinical condition all influence the meaning of a result.

SAA Compared With Fibrinogen and White Blood Cell Count

SAA, fibrinogen and the white blood cell count provide different information about the inflammatory response. They are complementary rather than interchangeable.

Serum Amyloid A

SAA is a rapidly responding acute-phase protein in horses. Its changing concentration can be useful when monitoring the development or resolution of inflammation over relatively short periods.

Fibrinogen

Fibrinogen is another acute-phase protein commonly measured in equine practice. Its response can be slower than that of SAA, and it may remain elevated after the initial inflammatory stimulus has started to resolve. It remains useful as part of routine laboratory assessment.

White Blood Cell Count

A complete blood count provides information about white blood cell numbers and other haematological findings. Changes in white blood cell count or differential may support investigation of infection or inflammation. A normal count does not exclude significant inflammatory disease, and an abnormal count is not specific to one cause.

Practical takeaway: SAA can add a responsive inflammatory marker to the assessment, while fibrinogen and haematology provide complementary information. The most appropriate combination depends on the clinical question.

When Should Equine Veterinarians Consider SAA Testing?

SAA may be considered when the result could help answer a clinical question, including:

• A horse presenting with fever or suspected systemic inflammation.

• Suspected infectious or inflammatory disease.

• Monitoring a horse during treatment.

• Assessing recovery following surgery or a significant inflammatory event.

• Following a condition where serial inflammatory measurements may help guide reassessment.

• Investigating unexpected clinical deterioration or recovery that is not progressing as anticipated.

Testing frequency should be determined by the veterinarian according to the disease, the horse's condition, the expected response and the intended use of the result.

In-House Equine SAA Testing: Bringing Results Closer to the Horse

Access to timely diagnostic information can be particularly useful in equine practice, where horses may be examined at clinics, breeding facilities, studs or referral hospitals. An in-house testing system may allow a practice to measure SAA and review the result during the same clinical visit, subject to the analyser's validated workflow and assay availability.

• Timely information: Obtain a quantitative SAA result without automatically sending every sample to an external laboratory.

• Serial monitoring: Repeat measurements can help track changes during treatment and recovery.

• Clinical workflow: Integrate inflammatory-marker testing into an appropriate in-house diagnostic process.

• Practical access: Consider testing at suitable veterinary settings where the equipment and assay are available.

In-house testing does not remove the need for external laboratory investigations when indicated. Suitability depends on assay validation, sample requirements, quality control, operator training and the clinical question.

Equine SAA Testing with the BIODX HV-FIA 3000

BIODX offers the HV-FIA 3000 Veterinary Immunofluorescence Analyser, a compact quantitative immunoassay platform with an equine SAA assay listed in the manufacturer's product brochure.

• Test: Equine Serum Amyloid A (eSAA)

• Sample type: Serum or plasma

• Sample volume: 10 μL

• Reaction time: Approximately 5 minutes

These specifications are manufacturer-stated and should be confirmed against the current assay instructions for use and the configuration supplied in Australia.

The HV-FIA 3000 may provide an option for quantitative inflammatory-marker testing as part of a broader equine testing menu. The platform also lists equine ACTH, insulin, Foal IgG and progesterone assays, making it relevant to practices seeking a multi-test equine and mixed-practice workflow.

A quantitative result should always be interpreted using appropriate assay-specific reference information, the clinical context and relevant quality-control requirements.

Call to action: Explore the BIODX HV-FIA 3000 to learn more about the analyser, available assays and suitability for your practice.

Conclusion: Make SAA Part of a Clinical Monitoring Strategy

Equine SAA testing can provide valuable information about systemic inflammation and how that response changes over time. Its rapid response makes it useful as a complementary marker when investigating suspected inflammatory disease and monitoring treatment or recovery.

For equine and mixed veterinary practices, an appropriate in-house SAA assay may help bring quantitative inflammatory-marker testing closer to the point of care.

Looking for an in-house equine SAA testing solution? Contact BIODX to discuss the HV-FIA 3000, its available equine assays and whether the platform suits your diagnostic workflow.

Clinical Disclaimer

This article is intended for veterinary education and does not replace professional examination, diagnosis or treatment. SAA results must be interpreted in conjunction with the horse's clinical presentation, appropriate assay instructions and other diagnostic findings.